In our previous study, we demonstrated that short-term intraperitoneal use of IL-2 at a dose of 400,000 IU combined with dexamethasone at a corresponding dose of 100 μg per mouse could upregulate Treg cells effectively and alleviate allergic airway disease in an asthma mouse model11. Here, IL2 is linked to asthma.